Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Linoleic acid metabolism	6/29	0.0027160397405107868	0.8365402400773223	0	0	4.137931034482758	24.44929836162695	PLA2G16;PLA2G2E;PLA2G2C;ALOX15;PLA2G2A;PLA2G6
alpha-Linolenic acid metabolism	5/25	0.007123209459613566	1.0	0	0	4.0	19.777587553293714	PLA2G16;PLA2G2E;PLA2G2C;PLA2G2A;PLA2G6
Adherens junction	8/72	0.026917281476999108	1.0	0	0	2.222222222222222	8.033303921239105	TCF7L1;PTPRB;YES1;CDH1;ERBB2;IQGAP1;NECTIN4;ACP1
Arginine and proline metabolism	6/49	0.03446921959858877	1.0	0	0	2.4489795918367343	8.247400503005839	ALDH3A2;P4HA1;CARNS1;CKB;ALDH18A1;CNDP1
Arachidonic acid metabolism	7/63	0.037195930953808354	1.0	0	0	2.222222222222222	7.314568681439843	PLA2G16;PLA2G2E;PLA2G2C;PTGES3;ALOX15;PLA2G2A;PLA2G6
Endometrial cancer	6/58	0.06880939588139882	1.0	0	0	2.068965517241379	5.537410293773416	CASP9;TCF7L1;GADD45B;CDH1;ERBB2;BAK1
Proteasome	5/45	0.07270586423397986	1.0	0	0	2.222222222222222	5.825184964955028	PSMD4;PSMA1;PSMD13;PSMC4;PSMB10
Ether lipid metabolism	5/47	0.08428928588938157	1.0	0	0	2.127659574468085	5.26276705761003	PLA2G16;PLA2G2E;PLA2G2C;PLA2G2A;PLA2G6
Hedgehog signaling pathway	5/47	0.08428928588938157	1.0	0	0	2.127659574468085	5.26276705761003	CCND2;CSNK1A1;BTRC;KIF7;CSNK1G2
Rap1 signaling pathway	15/206	0.09337267400518723	1.0	0	0	1.4563106796116503	3.4531406011045145	FLT1;FLT4;F2R;RAP1GAP;EFNA3;ADCY9;SIPA1L1;RRAS;CDH1;ADORA2B;TLN1;PFN1;FGF22;LAT;EPHA2
Histidine metabolism	3/23	0.10506660809461679	1.0	0	0	2.6086956521739126	5.877810696891578	ALDH3A2;CARNS1;CNDP1
Autophagy	10/128	0.10797771695705811	1.0	0	0	1.5625	3.4778599962772243	RPTOR;GABARAPL2;STK11;PRKAA1;RRAS;TP53INP2;ATG4C;TSC1;EIF2AK4;ATG4D
Thyroid cancer	4/37	0.11170784333278796	1.0	0	0	2.1621621621621623	4.739174827095357	TCF7L1;GADD45B;CDH1;BAK1
Regulation of lipolysis in adipocytes	5/55	0.13937991022954382	1.0	0	0	1.8181818181818181	3.582821649166955	PLA2G16;ADCY9;AQP7;ADRB2;PNPLA2
Ascorbate and aldarate metabolism	3/27	0.15038161447469178	1.0	0	0	2.222222222222222	4.210175820273459	ALDH3A2;UGT1A5;UGT1A4
Pyrimidine metabolism	5/57	0.15514033768438892	1.0	0	0	1.7543859649122806	3.2691669601382802	CANT1;NME3;TK2;TYMS;DCTPP1
Ras signaling pathway	15/232	0.18660888142951207	1.0	0	0	1.293103448275862	2.1707849943313935	RALBP1;FLT1;PLA2G2E;PLA2G2C;FLT4;PLA2G2A;PLA2G6;RASGRP1;PLA2G16;EFNA3;RRAS;EXOC2;FGF22;LAT;EPHA2
Pentose phosphate pathway	3/30	0.1877155615267818	1.0	0	0	2.0	3.345654864900365	GLYCTK;TALDO1;PGD
Circadian rhythm	3/31	0.20065196718317338	1.0	0	0	1.9354838709677418	3.1087420224475646	PER1;PRKAA1;BTRC
RNA polymerase	3/31	0.20065196718317338	1.0	0	0	1.9354838709677418	3.1087420224475646	POLR2D;POLR2E;POLR2L
beta-Alanine metabolism	3/31	0.20065196718317338	1.0	0	0	1.9354838709677418	3.1087420224475646	ALDH3A2;CARNS1;CNDP1
Basal cell carcinoma	5/63	0.20636211070548938	1.0	0	0	1.5873015873015872	2.504956879983314	TCF7L1;GADD45B;WNT5A;BAK1;KIF7
Sphingolipid metabolism	4/47	0.20718336704116536	1.0	0	0	1.7021276595744679	2.679406036964871	ACER2;NEU3;GBA2;CERS2
Glycerophospholipid metabolism	7/97	0.21155364258994297	1.0	0	0	1.4432989690721647	2.241842635816865	PLA2G16;PTDSS2;PLA2G2E;PLA2G2C;PLA2G2A;PEMT;PLA2G6
Other glycan degradation	2/18	0.22645148897005046	1.0	0	0	2.222222222222222	3.3004989638462865	NEU3;GBA2
Non-small cell lung cancer	5/66	0.23381942521025603	1.0	0	0	1.5151515151515151	2.201827497975576	CASP9;STAT5B;GADD45B;ERBB2;BAK1
Ribosome	10/153	0.2362142323082741	1.0	0	0	1.3071895424836601	1.8862955839307176	MRPL30;MRPL20;RNA5S12;RPLP1;RPS6;RPL36;MRPS21;RPL23A;FAU;RPS27A
Apelin signaling pathway	9/137	0.2472046870434335	1.0	0	0	1.313868613138686	1.8361820930540071	MYL4;GABARAPL2;HDAC5;PRKAA1;MEF2B;ADCY9;RRAS;CDH1;RPS6
AMPK signaling pathway	8/120	0.2519691354453672	1.0	0	0	1.3333333333333333	1.8379315698176057	RPTOR;SREBF1;CRTC2;STK11;PRKAA1;EEF2K;TSC1;EEF2
Hippo signaling pathway	10/160	0.27958919759892664	1.0	0	0	1.25	1.5930423807072653	TCF7L1;CCND2;CDH1;DCHS2;WNT5A;BMP8A;DCHS1;BTRC;GDF5;BIRC2
B cell receptor signaling pathway	5/71	0.2815854896327663	1.0	0	0	1.408450704225352	1.7849565976318464	IFITM1;PPP3CB;CR2;VAV1;CD22
Aldosterone-regulated sodium reabsorption	3/37	0.2816374857336128	1.0	0	0	1.6216216216216217	2.054812778279635	SLC9A3R2;HSD11B2;SFN
p53 signaling pathway	5/72	0.2913681345785638	1.0	0	0	1.3888888888888888	1.712732977852415	CASP9;PIDD1;CCND2;GADD45B;SFN
Focal adhesion	12/199	0.29380202083177825	1.0	0	0	1.2060301507537687	1.477204989358133	LAMA5;CCND2;FLT1;FLT4;ITGA11;ERBB2;PARVA;PIP5K1C;PARVB;TLN1;VAV1;BIRC2
Legionellosis	4/55	0.2953729340320737	1.0	0	0	1.4545454545454544	1.773842236930121	CASP9;EEF1G;CR1;NLRC4
RNA transport	10/165	0.3118918000294854	1.0	0	0	1.2121212121212122	1.4122411467844365	EIF5B;SNORD3B-1;EIF5;NUP210L;NUP155;RPP40;THOC1;GEMIN4;SAP18;EIF3A
PI3K-Akt signaling pathway	20/354	0.318692156807526	1.0	0	0	1.1299435028248588	1.2921239184362683	LAMA5;CRTC2;PRKAA1;FLT1;CSH2;FLT4;RPS6;F2R;TSC1;RPTOR;CASP9;STK11;EFNA3;CCND2;ITGA11;ERBB2;THEM4;IL6R;FGF22;EPHA2
Mannose type O-glycan biosynthesis	2/23	0.32060036735466374	1.0	0	0	1.7391304347826086	1.9783650312564471	B3GAT1;LARGE2
Renin-angiotensin system	2/23	0.32060036735466374	1.0	0	0	1.7391304347826086	1.9783650312564471	CMA1;KLK2
Pancreatic cancer	5/75	0.32103520904984706	1.0	0	0	1.3333333333333333	1.5149393018047932	CASP9;RALBP1;GADD45B;ERBB2;BAK1
Small cell lung cancer	6/93	0.32110195783620454	1.0	0	0	1.2903225806451613	1.465802039518082	CASP9;LAMA5;GADD45B;MAX;BAK1;BIRC2
Ferroptosis	3/40	0.3232493972692518	1.0	0	0	1.4999999999999998	1.693996688892286	FTMT;GPX4;ALOX15
Riboflavin metabolism	1/8	0.33662794865636386	1.0	0	0	2.5	2.721942421048515	ACP1
Bladder cancer	3/41	0.3371468638537048	1.0	0	0	1.4634146341463412	1.5910780182096236	CDH1;MMP1;ERBB2
Fat digestion and absorption	3/41	0.3371468638537048	1.0	0	0	1.4634146341463412	1.5910780182096236	PLA2G2E;PLA2G2C;PLA2G2A
Synaptic vesicle cycle	5/78	0.3510237868632946	1.0	0	0	1.282051282051282	1.3421811397066412	UNC13A;SLC17A7;AP2A2;ATP6V1E2;CPLX4
Porphyrin and chlorophyll metabolism	3/42	0.3510272087326468	1.0	0	0	1.4285714285714284	1.4955593439482697	FECH;UGT1A5;UGT1A4
Hematopoietic cell lineage	6/97	0.3569285827398046	1.0	0	0	1.2371134020618557	1.2744984316239885	CD2;CR2;CR1;DNTT;IL6R;CD22
Huntington disease	11/193	0.3718538023335192	1.0	0	0	1.1398963730569949	1.1276476239158606	COX8A;CASP9;TBPL2;POLR2D;PPIF;POLR2E;UQCR11;AP2A2;DNAL4;RCOR1;POLR2L
Basal transcription factors	3/45	0.3924009183942127	1.0	0	0	1.3333333333333333	1.2472949477860094	GTF2A2;TAF13;TBPL2
Synthesis and degradation of ketone bodies	1/10	0.40133341390034794	1.0	0	0	2.0	1.8259254820662505	OXCT2
Mitophagy	4/65	0.41006047139933866	1.0	0	0	1.2307692307692308	1.0971700171589474	GABARAPL2;RRAS;TFE3;USP30
Apoptosis	8/143	0.42422531374724404	1.0	0	0	1.1188811188811187	0.959430002289309	CASP9;PIDD1;GADD45B;CTSK;BAK1;LMNB2;BIRC2;TUBA8
Cell cycle	7/124	0.42665940706055616	1.0	0	0	1.129032258064516	0.9616749321100159	CCND2;TFDP1;GADD45B;MCM3;SFN;CDC6;CDC25B
Retinol metabolism	4/67	0.4327475179328833	1.0	0	0	1.1940298507462686	1.0001203826990046	RDH16;UGT1A5;UGT1A4;DHRS4L1
Endocrine and other factor-regulated calcium reabsorption	3/48	0.43306631871249	1.0	0	0	1.25	1.0460805021359667	ADCY9;KLK2;AP2A2
Valine, leucine and isoleucine degradation	3/48	0.43306631871249	1.0	0	0	1.25	1.0460805021359667	ALDH3A2;PCCA;OXCT2
Protein processing in endoplasmic reticulum	9/165	0.443294181978683	1.0	0	0	1.0909090909090908	0.8874781763568012	PPP1R15A;DNAJB1;SYVN1;HYOU1;EIF2AK4;BAK1;MARCH6;UBQLN4;TXNDC5
Glyoxylate and dicarboxylate metabolism	2/30	0.44657352514826887	1.0	0	0	1.3333333333333333	1.0748682963163632	PCCA;GLYCTK
Transcriptional misregulation in cancer	10/186	0.453202580319	1.0	0	0	1.075268817204301	0.8509850067631957	CCND2;FLT1;KMT2A;GADD45B;MAX;LMO2;TFE3;BAK1;PROM1;MEN1
Breast cancer	8/147	0.45476716013155544	1.0	0	0	1.0884353741496597	0.857654124612061	TCF7L1;GADD45B;CSNK1A1;FLT4;WNT5A;ERBB2;BAK1;FGF22
Mucin type O-glycan biosynthesis	2/31	0.46353362563600886	1.0	0	0	1.2903225806451613	0.9920985153401862	GALNT16;B4GALT5
Gastric cancer	8/149	0.46993598574671025	1.0	0	0	1.0738255033557047	0.8109087721804916	TCF7L1;GADD45B;CDH1;CSNK1A1;WNT5A;ERBB2;BAK1;FGF22
TGF-beta signaling pathway	5/90	0.4705185605943169	1.0	0	0	1.111111111111111	0.8376887467502594	TFDP1;AMHR2;BMP8A;SMAD9;GDF5
Fc gamma R-mediated phagocytosis	5/91	0.48023571472567267	1.0	0	0	1.0989010989010988	0.8060200255732013	MYO10;PIP5K1C;PLA2G6;VAV1;LAT
Rheumatoid arthritis	5/91	0.48023571472567267	1.0	0	0	1.0989010989010988	0.8060200255732013	FLT1;MMP1;CTSK;CCL3;ATP6V1E2
Non-homologous end-joining	1/13	0.48676267554205266	1.0	0	0	1.5384615384615385	1.107659375220991	DNTT
Melanoma	4/72	0.48826565745953704	1.0	0	0	1.111111111111111	0.7965507124555724	GADD45B;CDH1;BAK1;FGF22
Vascular smooth muscle contraction	7/132	0.49185149962456454	1.0	0	0	1.0606060606060606	0.7525831919041477	ADCY9;PLA2G2E;ADORA2B;PLA2G2C;GNA12;PLA2G2A;PLA2G6
Fructose and mannose metabolism	2/33	0.496510840077104	1.0	0	0	1.2121212121212122	0.8486666215153239	GMPPB;MPI
Inositol phosphate metabolism	4/74	0.5098528753630284	1.0	0	0	1.0810810810810811	0.7282519724998587	IMPA2;PI4KA;PIP5K1C;PLCH2
MAPK signaling pathway	15/295	0.5110951423360365	1.0	0	0	1.0169491525423728	0.6825757805947439	MAP4K2;FLT1;GADD45B;MAX;FLT4;RASGRP1;CDC25B;PPP3CB;EFNA3;RRAS;ERBB2;GNA12;CACNG1;FGF22;EPHA2
Pentose and glucuronate interconversions	2/34	0.5125071338352726	1.0	0	0	1.176470588235294	0.7864007628092599	UGT1A5;UGT1A4
Glutathione metabolism	3/56	0.5356989644779965	1.0	0	0	1.0714285714285714	0.6687674026318335	GSTM4;GPX4;PGD
Thiamine metabolism	1/15	0.5368361352216328	1.0	0	0	1.3333333333333333	0.8294165061381815	ACP1
Cardiac muscle contraction	4/78	0.5517212852986342	1.0	0	0	1.0256410256410255	0.6099613109295229	COX8A;MYL4;UQCR11;CACNG1
Epstein-Barr virus infection	10/201	0.5523179780186385	1.0	0	0	0.9950248756218906	0.5906779616132228	CASP9;CR2;CCND2;PSMD4;GADD45B;PSMC4;PSMD13;STAT2;ISG15;BAK1
Axon guidance	9/181	0.555066973103549	1.0	0	0	0.9944751381215469	0.5854141991509727	ENAH;SEMA4A;EFNA3;PPP3CB;RRAS;WNT5A;SEMA4C;RHOD;EPHA2
Complement and coagulation cascades	4/79	0.561890006637219	1.0	0	0	1.0126582278481011	0.5837459908567373	CR2;CR1;F2R;C4BPA
HIF-1 signaling pathway	5/100	0.5644459548061124	1.0	0	0	1.0	0.5719106399118082	FLT1;RPS6;ERBB2;ENO3;IL6R
Pathways in cancer	26/530	0.5691186498287897	1.0	0	0	0.9811320754716981	0.5530311291468017	LAMA5;MAX;FLT4;PTGER2;RASGRP1;CASP9;CCND2;CDH1;ERBB2;GNA12;PIM1;BAK1;IL6R;FGF22;GSTM4;STAT5B;RALBP1;TCF7L1;GADD45B;MMP1;STAT2;F2R;WNT5A;KIF7;ADCY9;BIRC2
Lysine degradation	3/59	0.5713815260202666	1.0	0	0	1.0169491525423728	0.5691845296161483	ALDH3A2;KMT2A;KMT5A
Ribosome biogenesis in eukaryotes	5/101	0.5733754172932677	1.0	0	0	0.9900990099009901	0.5507075230503586	SNORD3B-1;RNA5S12;REXO1;IMP3;RPP40
Nitrogen metabolism	1/17	0.5820286217003197	1.0	0	0	1.176470588235294	0.6367478285654856	CA12
Longevity regulating pathway	5/102	0.5822081971857422	1.0	0	0	0.9803921568627451	0.5303207530358068	RPTOR;STK11;PRKAA1;ADCY9;TSC1
Steroid hormone biosynthesis	3/60	0.5828910435264506	1.0	0	0	1.0	0.5397549994176116	HSD11B2;UGT1A5;UGT1A4
Chemical carcinogenesis	4/82	0.591620653904691	1.0	0	0	0.975609756097561	0.5120874505494942	SULT1A1;GSTM4;UGT1A5;UGT1A4
Glycerolipid metabolism	3/61	0.5942021207725078	1.0	0	0	0.9836065573770492	0.5120023739386589	ALDH3A2;GLYCTK;PNPLA2
Calcium signaling pathway	9/188	0.6010901477918724	1.0	0	0	0.9574468085106382	0.4873503440770302	P2RX7;PPP3CB;ADCY9;GNAL;ADORA2B;F2R;ERBB2;PPIF;ADRB2
Glycine, serine and threonine metabolism	2/40	0.60119891797304	1.0	0	0	1.0	0.5088294208836465	SRR;GLYCTK
Peroxisome	4/83	0.6012622374752512	1.0	0	0	0.963855421686747	0.4903364861494962	DHRS4L1;PEX11G;DECR2;PEX14
Thermogenesis	11/231	0.6093800775213675	1.0	0	0	0.9523809523809523	0.4717267665923641	RPTOR;COX8A;PRKAA1;ADCY9;RPS6;BMP8A;SIRT6;UQCR11;TSC1;SMARCA4;PNPLA2
Hypertrophic cardiomyopathy (HCM)	4/85	0.6201271748700885	1.0	0	0	0.9411764705882353	0.4497230129121684	MYBPC3;PRKAA1;ITGA11;CACNG1
Glycosaminoglycan degradation	1/19	0.6228154838888618	1.0	0	0	1.0526315789473684	0.4984262922061619	IDUA
Th17 cell differentiation	5/107	0.6248402405451496	1.0	0	0	0.9345794392523363	0.43949465144730016	STAT5B;PPP3CB;IL17D;IL6R;LAT
Colorectal cancer	4/86	0.6293463661035574	1.0	0	0	0.9302325581395349	0.4307660579611482	CASP9;TCF7L1;GADD45B;BAK1
Salmonella infection	4/86	0.6293463661035574	1.0	0	0	0.9302325581395349	0.4307660579611482	CCL3;PLEKHM2;NLRC4;PFN1
Regulation of actin cytoskeleton	10/214	0.6321038426069175	1.0	0	0	0.9345794392523363	0.42869307514954197	ENAH;RRAS;F2R;ITGA11;GNA12;IQGAP1;PIP5K1C;PFN1;VAV1;FGF22
Drug metabolism	5/108	0.6330463554564062	1.0	0	0	0.9259259259259258	0.4233441001393671	GSTM4;UGT1A5;NME3;UGT1A4;TK2
Shigellosis	3/65	0.6374113112791769	1.0	0	0	0.9230769230769231	0.41569858263660475	ELMO3;BTRC;PFN1
One carbon pool by folate	1/20	0.6416925793416899	1.0	0	0	1.0	0.4436459383541027	TYMS
mTOR signaling pathway	7/152	0.6417021441357289	1.0	0	0	0.9210526315789472	0.4086075302976567	RPTOR;STK11;PRKAA1;RPS6;WNT5A;TSC1;ATP6V1E2
Acute myeloid leukemia	3/66	0.6476960862533626	1.0	0	0	0.9090909090909091	0.3948488139467768	STAT5B;TCF7L1;PIM1
Aminoacyl-tRNA biosynthesis	3/66	0.6476960862533626	1.0	0	0	0.9090909090909091	0.3948488139467768	YARS;PARS2;TARS2
Arginine biosynthesis	1/21	0.6596258189717179	1.0	0	0	0.9523809523809523	0.3962690911289506	GPT2
ABC transporters	2/45	0.665369764985953	1.0	0	0	0.8888888888888888	0.3621443158089169	ABCA2;ABCC5
Glycosphingolipid biosynthesis	2/45	0.665369764985953	1.0	0	0	0.8888888888888888	0.3621443158089169	FUT6;A3GALT2
Dilated cardiomyopathy (DCM)	4/91	0.6732482464251353	1.0	0	0	0.8791208791208791	0.34781639730574376	MYBPC3;ADCY9;ITGA11;CACNG1
mRNA surveillance pathway	4/91	0.6732482464251353	1.0	0	0	0.8791208791208791	0.34781639730574376	DAZAP1;SSU72;SAP18;BCL2L2-PABPN1
Adipocytokine signaling pathway	3/69	0.6772948191670352	1.0	0	0	0.8695652173913043	0.338824888725687	STK11;PRKAA1;AGRP
Renin secretion	3/69	0.6772948191670352	1.0	0	0	0.8695652173913043	0.338824888725687	PPP3CB;PTGER2;ADRB2
Wnt signaling pathway	7/158	0.6813097466135722	1.0	0	0	0.8860759493670886	0.3400212212397225	VANGL1;PPP3CB;TCF7L1;CCND2;CSNK1A1;WNT5A;BTRC
Proximal tubule bicarbonate reclamation	1/23	0.6928469690097347	1.0	0	0	0.8695652173913043	0.31908358966713624	SLC38A3
Measles	6/138	0.6936048973128792	1.0	0	0	0.8695652173913043	0.31813286332552565	CASP9;STAT5B;CCND2;STAT2;EIF2AK4;BAK1
Amino sugar and nucleotide sugar metabolism	2/48	0.6997136081858564	1.0	0	0	0.8333333333333333	0.29757013234898655	GMPPB;MPI
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3/72	0.7050123870135998	1.0	0	0	0.8333333333333333	0.2912832550768055	TCF7L1;ITGA11;CACNG1
NF-kappa B signaling pathway	4/95	0.7056844804748206	1.0	0	0	0.8421052631578947	0.2935469919093557	PIDD1;GADD45B;BIRC2;LAT
JAK-STAT signaling pathway	7/162	0.7061186960436059	1.0	0	0	0.8641975308641975	0.300716483504727	STAT5B;CCND2;CSH2;STAT2;PIM1;IL17D;IL6R
Necroptosis	7/162	0.7061186960436059	1.0	0	0	0.8641975308641975	0.300716483504727	STAT5B;HIST3H2A;H2AFJ;STAT2;ALOX15;BIRC2;HIST1H2AB
Vitamin digestion and absorption	1/24	0.7082222339049663	1.0	0	0	0.8333333333333333	0.28749778737100123	SLC19A2
Malaria	2/49	0.7104927276749392	1.0	0	0	0.8163265306122448	0.2790176057147895	CR1;KLRB1
Cytokine-cytokine receptor interaction	13/294	0.7146390696396547	1.0	0	0	0.8843537414965986	0.2971231019609598	XCR1;AMHR2;GDF15;CSH2;BMP8A;CXCL17;GDF5;CLCF1;CCL3;TNFSF9;CD27;IL17D;IL6R
Parkinson disease	6/142	0.7194862015133059	1.0	0	0	0.8450704225352113	0.2782123358209349	CASP9;COX8A;GNAL;LRRK2;PPIF;UQCR11
N-Glycan biosynthesis	2/50	0.7209459791839935	1.0	0	0	0.7999999999999999	0.2617528554824198	MGAT5;ALG14
Vibrio cholerae infection	2/50	0.7209459791839935	1.0	0	0	0.7999999999999999	0.2617528554824198	ADCY9;ATP6V1E2
Metabolism of xenobiotics by cytochrome P450	3/74	0.722455815470999	1.0	0	0	0.8108108108108109	0.2635937966943547	GSTM4;UGT1A5;UGT1A4
PPAR signaling pathway	3/74	0.722455815470999	1.0	0	0	0.8108108108108109	0.2635937966943547	MMP1;AQP7;PLIN5
Pancreatic secretion	4/98	0.7284348779278988	1.0	0	0	0.8163265306122448	0.25865881578997496	ADCY9;PLA2G2E;PLA2G2C;PLA2G2A
Amyotrophic lateral sclerosis (ALS)	2/51	0.7310789651903944	1.0	0	0	0.7843137254901961	0.24567356984329963	CASP9;PPP3CB
Mineral absorption	2/51	0.7310789651903944	1.0	0	0	0.7843137254901961	0.24567356984329963	MT1X;MT1E
Folate biosynthesis	1/26	0.7367044256304639	1.0	0	0	0.7692307692307693	0.2350527061077511	QDPR
Chronic myeloid leukemia	3/76	0.739084180089673	1.0	0	0	0.7894736842105262	0.2386922002972212	STAT5B;GADD45B;BAK1
Hepatocellular carcinoma	7/168	0.7408637352815205	1.0	0	0	0.8333333333333333	0.2499488030031976	GSTM4;TCF7L1;GADD45B;CSNK1A1;WNT5A;BAK1;SMARCA4
Lysosome	5/123	0.7423591890762312	1.0	0	0	0.8130081300813008	0.24221306555432562	ABCA2;CLN3;IDUA;CTSK;DNASE2
Melanogenesis	4/101	0.7498448770134236	1.0	0	0	0.792079207920792	0.22803083128155077	TCF7L1;ADCY9;MC1R;WNT5A
T cell receptor signaling pathway	4/101	0.7498448770134236	1.0	0	0	0.792079207920792	0.22803083128155077	PPP3CB;RASGRP1;LAT;VAV1
Collecting duct acid secretion	1/27	0.7498862689651448	1.0	0	0	0.7407407407407407	0.2132101669113366	ATP6V1E2
Fatty acid elongation	1/27	0.7498862689651448	1.0	0	0	0.7407407407407407	0.2132101669113366	THEM4
Glycosaminoglycan biosynthesis	2/53	0.7504077852742062	1.0	0	0	0.7547169811320754	0.21670830680118947	CHST6;B3GAT3
Phospholipase D signaling pathway	6/148	0.7553912967971983	1.0	0	0	0.8108108108108109	0.22744815412465288	ADCY9;RRAS;F2R;GNA12;TSC1;PIP5K1C
Butanoate metabolism	1/28	0.7624087879510514	1.0	0	0	0.7142857142857142	0.19376600001083732	OXCT2
Phototransduction	1/28	0.7624087879510514	1.0	0	0	0.7142857142857142	0.19376600001083732	GRK1
Osteoclast differentiation	5/127	0.7670589994510474	1.0	0	0	0.7874015748031495	0.20881225056066524	PPP3CB;CTSK;STAT2;JUNB;FCGR2C
Pathogenic Escherichia coli infection	2/55	0.7685284162153218	1.0	0	0	0.7272727272727272	0.1914747203489268	CDH1;TUBA8
C-type lectin receptor signaling pathway	4/104	0.7699363530876122	1.0	0	0	0.7692307692307693	0.20111340452197826	PPP3CB;RRAS;STAT2;IL17D
Oxytocin signaling pathway	6/153	0.7826524992964198	1.0	0	0	0.7843137254901961	0.19220901041264157	PPP3CB;PRKAA1;ADCY9;EEF2K;CACNG1;EEF2
ECM-receptor interaction	3/82	0.7842396846897038	1.0	0	0	0.7317073170731706	0.17783457445402553	LAMA5;SV2B;ITGA11
Viral carcinogenesis	8/201	0.7925273344506804	1.0	0	0	0.7960199004975124	0.18509714022296506	STAT5B;HDAC5;GTF2A2;CCND2;TBPL2;HIST1H2BK;BAK1;HIST1H4E
FoxO signaling pathway	5/132	0.7953524382434503	1.0	0	0	0.7575757575757576	0.17346207880243836	GABARAPL2;STK11;PRKAA1;CCND2;GADD45B
Human cytomegalovirus infection	9/225	0.7978492599539114	1.0	0	0	0.7999999999999999	0.18066847734122668	CASP9;PPP3CB;ADCY9;PTGER2;GNA12;CCL3;TSC1;BAK1;IL6R
Systemic lupus erythematosus	5/133	0.8006749703651704	1.0	0	0	0.7518796992481203	0.1671430030702634	HIST3H2A;H2AFJ;HIST1H2BK;HIST1H4E;HIST1H2AB
VEGF signaling pathway	2/59	0.8013529002820844	1.0	0	0	0.6779661016949152	0.15013820630777816	CASP9;PPP3CB
Alcoholism	7/180	0.8014249468669339	1.0	0	0	0.7777777777777778	0.17217196278867253	HDAC5;HIST3H2A;H2AFJ;ADORA2B;HIST1H2BK;HIST1H4E;HIST1H2AB
Herpes simplex virus 1 infection	21/492	0.8027195498327405	1.0	0	0	0.8536585365853658	0.18759136016352254	ZNF283;STAT2;TSC1;EIF2AK4;ZNF57;CASP9;ZNF205;ZNF689;ZNF700;ZNF688;ZNF534;BAK1;ZNF599;SRSF6;ZNF555;ZNF665;ZNF136;ZNF124;ZNF564;BIRC2;ZNF233
ErbB signaling pathway	3/85	0.8042799356196909	1.0	0	0	0.7058823529411764	0.15374674713305503	STAT5B;ERBB2;NRG2
Propanoate metabolism	1/32	0.806540365201665	1.0	0	0	0.625	0.13437583301390715	PCCA
Base excision repair	1/33	0.8162287694193023	1.0	0	0	0.6060606060606061	0.12306703553305594	UNG
Cellular senescence	6/160	0.8168643739779579	1.0	0	0	0.7499999999999999	0.15171165211906248	PPP3CB;CCND2;RRAS;GADD45B;TSC1;BTRC
MicroRNAs in cancer	12/299	0.8206716096774825	1.0	0	0	0.802675585284281	0.1586345721141662	RPTOR;EFNA3;CCND2;MIR26A2;ERBB2;PIM1;IGF2BP1;MIR135B;MIR200B;MIR133B;BAK1;CDC25B
Insulin signaling pathway	5/137	0.8208780761188903	1.0	0	0	0.72992700729927	0.14407349424250715	RPTOR;SREBF1;PRKAA1;RPS6;TSC1
Ubiquitin mediated proteolysis	5/137	0.8208780761188903	1.0	0	0	0.72992700729927	0.14407349424250715	SYVN1;NHLRC1;WWP2;BTRC;BIRC2
Toxoplasmosis	4/113	0.8226434279131911	1.0	0	0	0.7079646017699115	0.13821765033879096	CASP9;LAMA5;PPIF;BIRC2
SNARE interactions in vesicular transport	1/34	0.8254324369271197	1.0	0	0	0.588235294117647	0.11285168470716885	VAMP1
Glutamatergic synapse	4/114	0.8278334479918896	1.0	0	0	0.7017543859649122	0.13259178568312602	PPP3CB;ADCY9;SLC17A7;SLC38A3
GABAergic synapse	3/89	0.8285426848935676	1.0	0	0	0.6741573033707865	0.1268001726406977	GABARAPL2;ADCY9;SLC38A3
Cytosolic DNA-sensing pathway	2/63	0.8299778549215587	1.0	0	0	0.6349206349206349	0.1183214345173536	POLR2E;POLR2L
Alanine, aspartate and glutamate metabolism	1/35	0.8341755971925006	1.0	0	0	0.5714285714285714	0.103606486053202	GPT2
Salivary secretion	3/90	0.8341902087803339	1.0	0	0	0.6666666666666666	0.120862556363351	ADCY9;AQP5;ADRB2
DNA replication	1/36	0.8424812699182175	1.0	0	0	0.5555555555555555	0.09522436030767889	MCM3
cGMP-PKG signaling pathway	6/166	0.8426824754400535	1.0	0	0	0.7228915662650601	0.1237337726371208	PPP3CB;MEF2B;ADCY9;GNA12;PPIF;ADRB2
Central carbon metabolism in cancer	2/65	0.8428493095437481	1.0	0	0	0.6153846153846154	0.10521051812214251	ERBB2;SIRT6
Chemokine signaling pathway	7/190	0.8431186379156546	1.0	0	0	0.7368421052631577	0.12574033528457515	GRK1;STAT5B;ADCY9;XCR1;STAT2;CCL3;VAV1
Th1 and Th2 cell differentiation	3/92	0.845005864491722	1.0	0	0	0.6521739130434782	0.10983372484053684	STAT5B;PPP3CB;LAT
Primary immunodeficiency	1/37	0.8503713249208762	1.0	0	0	0.5405405405405406	0.08761198488762709	UNG
Sphingolipid signaling pathway	4/119	0.851921877903696	1.0	0	0	0.6722689075630252	0.10773811694664917	ACER2;GNA12;NSMAF;CERS2
Adrenergic signaling in cardiomyocytes	5/145	0.8563159481665291	1.0	0	0	0.689655172413793	0.10697646387244193	MYL4;ADCY9;ADRB2;CACNG1;SCN4B
Cell adhesion molecules (CAMs)	5/145	0.8563159481665291	1.0	0	0	0.689655172413793	0.10697646387244193	CD2;CDH1;VTCN1;CD22;MPZL1
Fc epsilon RI signaling pathway	2/68	0.860502636162266	1.0	0	0	0.588235294117647	0.08837564694787858	VAV1;LAT
Glycolysis / Gluconeogenesis	2/68	0.860502636162266	1.0	0	0	0.588235294117647	0.08837564694787858	ALDH3A2;ENO3
Staphylococcus aureus infection	2/68	0.860502636162266	1.0	0	0	0.588235294117647	0.08837564694787858	DSG1;FCGR2C
Influenza A	6/171	0.8618729388874423	1.0	0	0	0.7017543859649122	0.10431398025689025	CASP9;DNAJB1;STAT2;TMPRSS4;EIF2AK4;BCL2L2-PABPN1
Amoebiasis	3/96	0.8648106182658194	1.0	0	0	0.625	0.09077795902611915	LAMA5;GNAL;SERPINB6
Pyruvate metabolism	1/39	0.8649866555134298	1.0	0	0	0.5128205128205128	0.07438010221608295	ALDH3A2
Prostate cancer	3/97	0.8694002721574682	1.0	0	0	0.6185567010309279	0.08656802931150201	CASP9;TCF7L1;ERBB2
Prolactin signaling pathway	2/70	0.8712429450339811	1.0	0	0	0.5714285714285714	0.0787625225498065	STAT5B;CCND2
Non-alcoholic fatty liver disease (NAFLD)	5/149	0.871720550894918	1.0	0	0	0.6711409395973154	0.09213850710843985	COX8A;SREBF1;PRKAA1;UQCR11;IL6R
Nicotine addiction	1/40	0.8717504251826977	1.0	0	0	0.5	0.06862605284591321	SLC17A7
Platelet activation	4/124	0.8730902649815165	1.0	0	0	0.6451612903225806	0.08755892398339275	ADCY9;F2R;TLN1;RASGRP1
Oocyte meiosis	4/125	0.8769959948339774	1.0	0	0	0.64	0.08400182624919345	PPP3CB;ADCY9;SPDYC;BTRC
Phosphatidylinositol signaling system	3/99	0.8781684208695373	1.0	0	0	0.6060606060606061	0.07873750329026426	IMPA2;PI4KA;PIP5K1C
Progesterone-mediated oocyte maturation	3/99	0.8781684208695373	1.0	0	0	0.6060606060606061	0.07873750329026426	ADCY9;SPDYC;CDC25B
Inflammatory mediator regulation of TRP channels	3/100	0.8823533306415342	1.0	0	0	0.6	0.07509762093621879	ADCY9;PTGER2;PLA2G6
Tryptophan metabolism	1/42	0.8842793063304941	1.0	0	0	0.47619047619047616	0.05856300421956226	ALDH3A2
Bacterial invasion of epithelial cells	2/74	0.8904734986911036	1.0	0	0	0.5405405405405406	0.06270374958254536	CDH1;ELMO3
Leishmaniasis	2/74	0.8904734986911036	1.0	0	0	0.5405405405405406	0.06270374958254536	CR1;FCGR2C
Cushing syndrome	5/155	0.892191742499279	1.0	0	0	0.6451612903225806	0.0735962655119009	TCF7L1;ADCY9;KMT2A;WNT5A;MEN1
Hepatitis C	5/155	0.892191742499279	1.0	0	0	0.6451612903225806	0.0735962655119009	CASP9;STAT2;IFIT1B;EIF2AK4;BAK1
Glucagon signaling pathway	3/103	0.8941493670111881	1.0	0	0	0.5825242718446602	0.06517423722567385	CRTC2;PPP3CB;PRKAA1
Gastric acid secretion	2/75	0.8948461559431564	1.0	0	0	0.5333333333333333	0.0592551830845253	ADCY9;KCNJ10
Glioma	2/75	0.8948461559431564	1.0	0	0	0.5333333333333333	0.0592551830845253	GADD45B;BAK1
Fatty acid degradation	1/44	0.8955853061573006	1.0	0	0	0.45454545454545453	0.05012627322480098	ALDH3A2
Vasopressin-regulated water reabsorption	1/44	0.8955853061573006	1.0	0	0	0.45454545454545453	0.05012627322480098	ADCY9
Human papillomavirus infection	12/330	0.9036752475739553	1.0	0	0	0.7272727272727272	0.0736619800299901	LAMA5;TCF7L1;CCND2;CSNK1A1;TBPL2;STAT2;WNT5A;ITGA11;TSC1;ISG15;BAK1;ATP6V1E2
cAMP signaling pathway	7/212	0.9102489016760925	1.0	0	0	0.660377358490566	0.06210003677512062	ADCY9;RRAS;PTGER2;F2R;GHRL;ADRB2;VAV1
Cysteine and methionine metabolism	1/47	0.9105090567783704	1.0	0	0	0.42553191489361697	0.03989422673431822	MAT1A
RNA degradation	2/79	0.9107606472852537	1.0	0	0	0.5063291139240506	0.047329191130890166	PAN2;ENO3
Insulin resistance	3/108	0.9114649563237461	1.0	0	0	0.5555555555555555	0.051501184313357255	SREBF1;CRTC2;PRKAA1
Neuroactive ligand-receptor interaction	12/338	0.9189807709672625	1.0	0	0	0.7100591715976331	0.0599929567180334	KISS1;P2RX7;MC1R;CSH2;ADORA2B;PTGER2;F2R;RLN3;GHRL;TAC3;ADRB2;PTGDR
Ovarian steroidogenesis	1/49	0.919254474341766	1.0	0	0	0.4081632653061224	0.034364200583535946	ADCY9
Cholesterol metabolism	1/50	0.9233015685863551	1.0	0	0	0.39999999999999997	0.03191974852547144	VAPA
Human T-cell leukemia virus 1 infection	7/219	0.925646181774397	1.0	0	0	0.639269406392694	0.04939200669208585	STAT5B;PPP3CB;CRTC2;ADCY9;CCND2;TBPL2;TLN1
Tight junction	5/170	0.9314526047817695	1.0	0	0	0.588235294117647	0.04177057104107132	STK11;PRKAA1;MYH3;ERBB2;TUBA8
Fanconi anemia pathway	1/54	0.9375622230779963	1.0	0	0	0.37037037037037035	0.02387857483587084	FANCA
Gap junction	2/88	0.9386840239616273	1.0	0	0	0.45454545454545453	0.028761981412220677	ADCY9;TUBA8
NOD-like receptor signaling pathway	5/178	0.946680501203607	1.0	0	0	0.5617977528089887	0.030782934075452524	P2RX7;GABARAPL2;STAT2;NLRC4;BIRC2
IL-17 signaling pathway	2/93	0.9503836736321627	1.0	0	0	0.43010752688172044	0.021887960833825593	MMP1;IL17D
Viral myocarditis	1/59	0.9517220547219089	1.0	0	0	0.3389830508474576	0.01677364276098951	CASP9
Long-term depression	1/60	0.95414298697788	1.0	0	0	0.3333333333333333	0.015647245745596144	GNA12
Circadian entrainment	2/97	0.9581767039032599	1.0	0	0	0.41237113402061853	0.017617759662583495	PER1;ADCY9
Kaposi sarcoma-associated herpesvirus infection	5/186	0.9587800861737528	1.0	0	0	0.5376344086021505	0.022630938800278836	CASP9;GABARAPL2;PPP3CB;STAT2;BAK1
Purine metabolism	3/129	0.9594354431483884	1.0	0	0	0.46511627906976744	0.01926058026089093	ADCY9;CANT1;NME3
Relaxin signaling pathway	3/130	0.9609575692842738	1.0	0	0	0.46153846153846156	0.018380780149132046	ADCY9;MMP1;RLN3
Choline metabolism in cancer	2/99	0.9616193258375976	1.0	0	0	0.40404040404040403	0.015812774876077424	TSC1;PIP5K1C
Natural killer cell mediated cytotoxicity	3/131	0.9624259105310855	1.0	0	0	0.4580152671755725	0.017541156574629197	PPP3CB;LAT;VAV1
AGE-RAGE signaling pathway in diabetic complications	2/100	0.9632369873558141	1.0	0	0	0.39999999999999997	0.014982321868347009	STAT5B;PIM1
Endocytosis	7/244	0.9634015428891836	1.0	0	0	0.5737704918032787	0.02139302319519856	EHD1;GRK1;SNX2;RAB35;VPS37D;PIP5K1C;AP2A2
Cortisol synthesis and secretion	1/65	0.9645452489317999	1.0	0	0	0.3076923076923077	0.011107241028940524	ADCY9
Oxidative phosphorylation	3/133	0.9652081031256262	1.0	0	0	0.45112781954887216	0.015975135331615462	COX8A;UQCR11;ATP6V1E2
Chagas disease (American trypanosomiasis)	2/103	0.9677062755799263	1.0	0	0	0.38834951456310673	0.01274822216284486	GNAL;CCL3
Long-term potentiation	1/67	0.9680129340715097	1.0	0	0	0.29850746268656714	0.00970442691065804	PPP3CB
Toll-like receptor signaling pathway	2/104	0.9690762134019278	1.0	0	0	0.38461538461538464	0.0120815456087189	CTSK;CCL3
Amphetamine addiction	1/68	0.9696175495526317	1.0	0	0	0.2941176470588235	0.009074577660222398	PPP3CB
Epithelial cell signaling in Helicobacter pylori infection	1/68	0.9696175495526317	1.0	0	0	0.2941176470588235	0.009074577660222398	ATP6V1E2
Renal cell carcinoma	1/69	0.9711417402987961	1.0	0	0	0.2898550724637681	0.00848778197469868	TFE3
Parathyroid hormone synthesis, secretion and action	2/106	0.9716500119085215	1.0	0	0	0.3773584905660377	0.010852682798281577	ADCY9;GNA12
Signaling pathways regulating pluripotency of stem cells	3/139	0.9724341820362676	1.0	0	0	0.4316546762589928	0.012065993490628802	WNT5A;ESRRB;SMAD9
RIG-I-like receptor signaling pathway	1/70	0.972589533427257	1.0	0	0	0.2857142857142857	0.007940897858985217	ISG15
Alzheimer disease	4/171	0.9741278417674597	1.0	0	0	0.4678362573099415	0.012263265296528252	CASP9;COX8A;PPP3CB;UQCR11
Proteoglycans in cancer	5/201	0.9749433026571618	1.0	0	0	0.4975124378109453	0.012624856117408741	RRAS;RPS6;WNT5A;ERBB2;IQGAP1
Bile secretion	1/72	0.9752710378445755	1.0	0	0	0.27777777777777773	0.006955516411879717	ADCY9
TNF signaling pathway	2/110	0.9761915809876566	1.0	0	0	0.3636363636363636	0.008762334485908308	JUNB;BIRC2
Thyroid hormone synthesis	1/74	0.9776904281936729	1.0	0	0	0.2702702702702703	0.00609789044447976	ADCY9
Pertussis	1/76	0.9798733026216075	1.0	0	0	0.2631578947368421	0.005350525977491548	C4BPA
Tuberculosis	4/179	0.9806620036282767	1.0	0	0	0.44692737430167595	0.008727339203546632	CASP9;PPP3CB;CR1;FCGR2C
Human immunodeficiency virus 1 infection	5/212	0.9828046988607574	1.0	0	0	0.4716981132075472	0.008181536439122956	CASP9;PPP3CB;APOBEC3H;BAK1;BTRC
Phagosome	3/152	0.9835125918696039	1.0	0	0	0.3947368421052631	0.006562436097584378	ATP6V1E2;FCGR2C;TUBA8
Taste transduction	1/83	0.9859645609779344	1.0	0	0	0.24096385542168675	0.0034059921056594548	TAS2R10
Insulin secretion	1/86	0.9879740196694372	1.0	0	0	0.23255813953488372	0.0028136924328252115	ADCY9
Hepatitis B	3/163	0.989424215322232	1.0	0	0	0.36809815950920244	0.00391365855217165	CASP9;STAT5B;STAT2
Protein digestion and absorption	1/90	0.9902133488804308	1.0	0	0	0.2222222222222222	0.002185523367001884	PGA5
Dopaminergic synapse	2/131	0.9906225720039081	1.0	0	0	0.30534351145038163	0.002876846685028434	PPP3CB;GNAL
Morphine addiction	1/91	0.9907047643496917	1.0	0	0	0.21978021978021978	0.002052462844095697	ADCY9
GnRH signaling pathway	1/93	0.9916148544307698	1.0	0	0	0.21505376344086022	0.0018108599286685806	ADCY9
Spliceosome	2/134	0.9918061738095247	1.0	0	0	0.29850746268656714	0.002455994057658477	THOC1;SRSF6
Estrogen signaling pathway	2/137	0.9928432555950474	1.0	0	0	0.291970802919708	0.002097073502741547	ADCY9;KRT26
Fluid shear stress and atherosclerosis	2/139	0.9934620548293828	1.0	0	0	0.28776978417266186	0.0018876003302306832	GSTM4;PRKAA1
Aldosterone synthesis and secretion	1/98	0.9935192823457568	1.0	0	0	0.2040816326530612	0.0013268997301213528	ADCY9
Retrograde endocannabinoid signaling	2/148	0.9956565181732089	1.0	0	0	0.2702702702702703	0.0011764708507407508	ADCY9;SLC17A7
Cholinergic synapse	1/112	0.9968503216903181	1.0	0	0	0.17857142857142855	5.633301761622566E-4	ADCY9
Leukocyte transendothelial migration	1/112	0.9968503216903181	1.0	0	0	0.17857142857142855	5.633301761622566E-4	VAV1
Serotonergic synapse	1/113	0.9970085519676813	1.0	0	0	0.17699115044247787	5.302533373988125E-4	ALOX15
Thyroid hormone signaling pathway	1/116	0.9974371246909948	1.0	0	0	0.17241379310344826	4.4244225793241656E-4	CASP9
Olfactory transduction	8/444	0.999881189571762	1.0	0	0	0.36036036036036034	4.281711234452022E-5	OR8B12;OR4F15;GNAL;OR2L5;OR10G3;OR5B17;OR2A4;OR7E24
